Histone deacetylases 3 (HDAC3) has antitumor efficacy in various cancers through histone modification of p53 and Bax and is reported to mediate inflammatory response and LPS tolerance in human macrophages and monocytes.261. The gene discussed is HDAC3; the disease is cancer.